Texas can’t spend $50M for ibogaine trials. Feds may fill the gap
- Texas reserved $50 million for ibogaine trials, but the funding required a matching contribution from another source.
- No drug company submitted a proposal that met the requirements for the Texas funding.
- The federal government offered to match state investments in psychedelic research, including studies involving serious mental illness.
- At least $50 million was allocated for research involving serious mental illness, but ARPA-H had spent none of it.
25 Articles
25 Articles
Your Alaska Link
Texas can’t spend $50M for ibogaine trials. Feds may fill the gap
(The Center Square) – Texas set aside $50 million for the psychoactive drug ibogaine trials on the condition that someone else match it. No drug company submitted a qualifying proposal. The federal government has offered to match state investments instead.
Texas can’t spend $50M for ibogaine trials. Feds may fill the gap - The Daily Bo Snerdley
(The Center Square) – Texas set aside $50 million for the psychoactive drug ibogaine trials on the condition that someone else match it. No drug company submitted a qualifying proposal. The federal government has offered to match state investments instead. Lt. Gov. Dan Patrick and Texas House Speaker Dustin Burrows said March 31 that the Texas Health and Human Services Commission had announced the day before that no drug company submitted a pr…
Coverage Details
Bias Distribution
- 42% of the sources are Center, 42% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
